Heparin disaccharide IV-S sodium, with the CAS number 136098-08-3, is a synthetic oligosaccharide derived from heparin, a naturally occurring anticoagulant. This compound consists of a repeating disaccharide unit that typically includes glucuronic acid and N-acetylglucosamine, which are characteristic of heparin's structure. Heparin disaccharides are known for their ability to bind to various proteins, including antithrombin, thereby enhancing its anticoagulant activity. The sodium salt form indicates that it is soluble in water, making it suitable for various biological applications. This compound is often used in research and therapeutic contexts, particularly in studies related to blood coagulation and vascular biology. Its structural features contribute to its biological activity, influencing processes such as cell signaling and inflammation. Overall, heparin disaccharide IV-S sodium serves as a valuable tool in both clinical and laboratory settings, providing insights into the mechanisms of anticoagulation and potential therapeutic interventions.

heparin disaccharide iv-S sodium

136098-08-3: Heparin Unsaturated Disaccharide IV-S, Disodium Salt

Heparin is a complex carbohydrate that has been modified by the addition of a sugar and a sulfate group. It is used in the treatment of thrombosis, deep vein thrombosis, pulmonary embolism, and other blood clots. Heparin disaccharide IV-S disodium salt (HDS) is an intravenous form of heparin that consists of sodium salts of two saccharides: heparin disaccharide and sodium disulfate. HDS has been shown to be more potent than unfractionated heparin in animal models, as well as being more effective in preventing clot formation in humans. This drug also exhibits less frequent side effects such as skin rash, itching, or hives.

CAS 136098-08-3: heparin disaccharide iv-S sodium

Heparin disaccharide IV-S disodium salt

Ref: 3D-OH28909

Heparin Disaccharide IV-S Disodium Salt

Ref: 4Z-H-026009